
Kryxana (Ribociclib 200 mg) is an oral anticancer medicine used in the treatment of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer.
| Manufacturer | NOVARTIS |
| Generic Name | Ribociclib |
| Strength | 200 mg |
| Pack size | 21 Tablets |
| Used For | Metastatic breast cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries. |

Authentic Medicines

Fast Delivery

Secure Payment

24/7 Support
| Package | USD | GBP | AUD | PHP | TND | KRW | RON | HKD | MYR | THB | SGD | AED | SAR | QAR | KWD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21 Tablets | $325 | £241 | A$453 | ₱20,374 | د.ت946.08 | ₩435,208 | lei 1,471 | HK$2,549 | RM1,322 | ฿10,732 | S$412 | د.إ1,193.73 | ر.س1,220.38 | ر.ق1,183.33 | د.ك99.125 |
Ribociclib is a targeted anticancer medicine known as a CDK4/6 (cyclin-dependent kinase 4 and 6) inhibitor. It works by blocking CDK4 and CDK6 proteins, which are involved in the growth and division of cancer cells. By stopping these proteins, Ribociclib slows or prevents cancer cells from multiplying, helping control the progression of hormone receptor-positive breast cancer.
Disclaimer
All information on this website is for educational purposes only. Medicines should be used only with a doctor’s prescription and supervision. We do not provide medical advice, and product details may change without notice. Always consult a healthcare professional before using any medication.